AIMS65 score is an objective, rapid, and easily derived prognostic scoring system designed specifically for risk stratification in adult patients presenting with acute upper gastrointestinal bleeding (UGIB) 1,2. Comprising five readily available clinical and laboratory variables—Albumin, International Normalized Ratio (INR), Mental Status, Systolic Blood Pressure, and Age—the score provides clinicians with a powerful metric to forecast in-hospital mortality, length of hospital stay, and the requirement for intensive care unit (ICU) admission 1,2. Because acute UGIB remains a critical medical emergency associated with significant healthcare utilization and mortality, validated prediction rules like AIMS65 assist multidisciplinary healthcare teams in rapidly identifying high-risk individuals who mandate immediate aggressive resuscitation and urgent endoscopic intervention.

Etiology & Risk Factors

  • Peptic Ulcer Disease (PUD): Accounts for roughly 50% of all non-variceal UGIB cases, driven predominantly by Helicobacter pylori infection and the widespread use of non-steroidal anti-inflammatory drugs (NSAIDs) and low-dose aspirin 1,2.
  • Portal Hypertension & Variceal Hemorrhage: Esophageal and gastric varices resulting from chronic liver disease, cirrhosis, and hepatic schistosomiasis represent a major high-risk etiology with substantial mortality 1,1.1.
  • Mallory-Weiss Tears: Longitudinal mucosal lacerations at the gastroesophageal junction typically precipitated by severe retching, vomiting, or coughing episodes 1.2,1.2.1.
  • Malignancy: Gastric adenocarcinoma, esophageal squamous cell carcinoma, and gastrointestinal stromal tumors (GISTs) that undergo central necrosis and chronic mucosal ulceration 1.2.1.
  • Coagulopathies & Antithrombotic Therapy: Iatrogenic anticoagulation with vitamin K antagonists (warfarin), direct oral anticoagulants (DOACs), and antiplatelet aggregants (clopidogrel, ticagrelor) dramatically exacerbate bleeding risk and elevate the AIMS65 score via INR and systemic compromise 1.1.1,1.2.1.
  • Erosive Gastroduodenitis & Esophagitis: Severe mucosal inflammation secondary to alcohol abuse, severe physiological stress (Curling ulcers in burns, Cushing ulcers in neurotrauma), or severe gastroesophageal reflux disease (GERD) 1.1.4,1.2.1.

Pathophysiology

The pathophysiological sequence underlying a high AIMS65 score involves acute intravascular volume depletion coupled with multi-organ metabolic stress. When a major arterial vessel (such as the gastroduodenal artery in posterior duodenal ulcers) or dilated submucosal variceal channel erodes, rapid blood loss precipitates hypovolemic shock. Systemic arterial hypotension (systolic blood pressure $\le$ 90 mmHg) triggers compensatory sympathetic nervous system activation, shunting blood away from the splanchnic circulation, skin, and kidneys toward the cerebral and coronary beds. In elderly patients (age $\ge$ 65 years), physiological cardiovascular reserve is inherently diminished, predisposing them rapidly to myocardial ischemia and multi-organ failure. Furthermore, underlying chronic liver disease impairs hepatocellular synthetic function, resulting in depressed serum albumin (< 3.0 g/dL) and elevated coagulation times (INR > 1.5). This hepatic synthetic failure impairs hemostatic plug formation, perpetuating the hemorrhage and creating a self-reinforcing vicious cycle of coagulopathy, tissue hypoperfusion, and altered mental status resulting from cerebral hypoxemia or hepatic encephalopathy 1,1.1,1.2.2.

AIMS65 score — Pathophysiological Cascade & Clinical Flowchart 1 Acute Luminal Vascular Rupture Arterial or mucosal erosion in the upper gastrointestinal tract precipitates acute hemorrhage. 2 Systemic Hypoperfusion & Metabolic Strain Acute blood loss leads to tissue hypoperfusion, organ dysfunction, and coagulopathy. 3 Multi-System Physiological Compromise Impaired hepatic synthetic function (low albumin), coagulopathy (elevated INR), and hypovolemia manifest. 4 Clinical Score Elevation (AIMS65 ≥ 2) Accumulation of risk points for age, blood pressure, mental status, INR, and albumin forecasts high mortality. 5 Urgent Interventional & Intensive Care Timely EGD, aggressive ICU resuscitation, and targeted hemostasis mitigate mortality and morbidity.

Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Patients classically present with acute hematemesis (bright red emesis or "coffee-ground" vomitus indicating partial gastric acid digestion of blood), melena (dark, tarry, foul-smelling stools reflecting degraded hemoglobin iron processed by colonic bacteria), or hematochezia (bright red or maroon stools passed per rectum in massive, rapid upper GI hemorrhage). Vague epigastric pain, dyspepsia, generalized weakness, lightheadedness, and syncope are frequent presenting complaints 1.1.1,1.2.1.
  • Physical Examination & Named Clinical Signs: Tachycardia and orthostatic hypotension serve as early bedside indicators of significant volume depletion ($\ge$ 15-20% blood volume loss). Cool, clammy extremities, delayed capillary refill, and confusion or lethargy denote progressed hypovolemic shock. Stigmata of chronic liver disease—such as jaundice, palmar erythema, spider angiomata, ascites, splenomegaly, and asterixis—strongly implicate acute variceal bleeding. Abdominal tenderness localized to the epigastrium points toward active peptic ulceration, while rectal examination confirms the presence of melena or blood 1.1.1,1.2.1.

Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationUrgent esophagogastroduodenoscopy (EGD) performed within 24 hours (or within 12 hours for high-risk instability) demonstrating active arterial spurting, a visible vessel, or an adherent clot (Forrest Class I-II) 1,1.1,1.1.5.
Laboratory PanelComplete blood count revealing acute normocytic anemia (though initial hemoglobin may be deceptively normal due to acute hemoconcentration before fluid resuscitation), elevated blood urea nitrogen (BUN) out of proportion to serum creatinine due to upper GI protein digestion and absorption, and coagulopathy (elevated INR) 1.1.1,1.2.1.
Imaging / Radiology (X-ray, US, CT, MRI)Upright chest and abdominal radiography to evaluate for free air indicating hollow viscus perforation. Contrast-enhanced computed tomography angiography (CTA) is reserved for obscure bleeding or cases where endoscopy fails to localize active arterial hemorrhage ($>0.5$ mL/min) 1.1.1.
ECG / Histopathology / Procedural12-lead ECG to rule out secondary myocardial ischemia or acute coronary syndrome precipitated by severe anemia and tachycardia in elderly patients. Histopathological biopsy of gastric margins during EGD to rule out malignancy and test for H. pylori 1.1.1.

Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
AlbuminSerum albumin < 3.0 g/dL (<30 g/L) awards 1 point, reflecting chronic systemic illness, malnutrition, or hepatic synthetic dysfunction 1.2.2,1.2.3.
INRInternational Normalized Ratio > 1.5 awards 1 point, indicating significant coagulopathy, vitamin K antagonist use, or severe liver impairment 1.2.2,1.2.3.
Mental StatusAltered mental status (disorientation, lethargy, stupor, or coma) awards 1 point, reflecting cerebral hypoperfusion or encephalopathy 1.2.2,1.2.3.
Systolic Blood PressureSystolic blood pressure $\le$ 90 mmHg awards 1 point, signifying hemodynamic instability and decompensated shock 1.2.2,1.2.3.
AgeAge $\ge$ 65 years awards 1 point, accounting for decreased physiological reserve and higher comorbidity burden 1.2.2,1.2.3.
Risk Interpretation & MortalityTotal score ranges from 0 to 5 points. A score of 0 corresponds to minimal mortality ($<0.5\%$), whereas scores $\ge$ 2 indicate high risk (associated with substantially increased in-hospital mortality rates ranging from 10% to over 40%, mandatory ICU admission, and extended hospital stays) 1.1.2,1.2.2,1.2.3.

Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Lower Gastrointestinal Bleeding (LGIB)Presents predominantly with hematochezia without hematemesis; upper endoscopy is negative, localizing pathology to the colon or terminal ileum via colonoscopy or CTA 1.1.1.
Pseudo-Melena / Dietary MimicsIngestion of bismuth subsalicylate, iron supplements, activated charcoal, blueberries, or dark licorice produces black stools, but the patient lacks anemia, hemodynamic instability, or positive fecal occult blood testing 1.1.1.
HemoptysisExpectoration of bright red, frothy blood originating from the respiratory tract, frequently accompanied by pleuritic chest pain, cough, and a normal gastrointestinal examination 1.1.1.
Aortoenteric FistulaCatastrophic bleeding occurring typically in patients with a history of prior abdominal aortic aneurysm repair or aortic graft placement, often preceded by a "sentinel bleed" 1.1.1.

Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Secure two large-bore peripheral intravenous lines (16-gauge or 18-gauge) or a central venous catheter. Administer rapid volume resuscitation using isotonic crystalloids (Normal Saline or Lactated Ringer's) while cross-matching packed red blood cells (PRBCs). Implement a restrictive transfusion strategy aiming for a target hemoglobin threshold of 7.0 g/dL (or 8.0 g/dL in patients with pre-existing cardiovascular disease). Promptly reverse coagulopathy using fresh frozen plasma (FFP), vitamin K, or specific reversal agents (e.g., prothrombin complex concentrate [PCC] for warfarin) 1.1.1,1.2.4.
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing): Administer an initial intravenous proton pump inhibitor bolus of pantoprazole 80 mg IV, followed immediately by a continuous infusion of pantoprazole 8 mg/h for 72 hours to maintain gastric pH $>6.0$ and stabilize clot formation. For suspected variceal hemorrhage, initiate vasoactive therapy immediately prior to endoscopy with octreotide 50 mcg IV bolus followed by a continuous infusion of 50 mcg/h for 2 to 5 days, alongside empirical antibiotic prophylaxis with ceftriaxone 1 g IV every 24 hours to prevent spontaneous bacterial peritonitis and sepsis 1.1.1.
  • Surgical / Interventional Indications: Urgent therapeutic EGD (utilizing bipolar electrocoagulation, hemoclips, or argon plasma coagulation for non-variceal ulcers, and variceal band ligation or cyanoacrylate injection for varices) is mandatory. Emergency surgical intervention or transjugular intrahepatic portosystemic shunt (TIPS) placement is indicated for refractory arterial hemorrhage, hemodynamic instability unresponsive to massive transfusion, or recurrent rebleeding failing secondary endoscopic attempts 1.1.1,1.2.2.

Complications & Prognosis

  • Acute Complications: Exsanguinating hypovolemic shock, aspiration pneumonia secondary to massive hematemesis, acute kidney injury from renal hypoperfusion, acute myocardial infarction due to oxygen supply-demand mismatch, and multi-organ dysfunction syndrome (MODS) 1.1.1.
  • Prognosis & Stratification Outcomes: The AIMS65 score exhibits exceptional calibration for predicting in-hospital mortality, outperforming traditional pre-endoscopy scoring systems such as the Rockall score in specific clinical cohorts 1.1.2,1.1.5. Patients with an AIMS65 score of 0 or 1 experience extremely low inpatient mortality (under 1%) and may be candidates for early discharge or outpatient management after successful index endoscopy. Conversely, patients with scores $\ge$ 2 experience exponentially rising mortality rates, prolonged hospital admissions, and a high requirement for critical care resources, necessitating rigorous inpatient monitoring and multidisciplinary gastroenterology management 1.1.2,1.1.5,1.2.2.